Plain-English translation of NCT07280715 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing whether using a smartphone app and wearable activity tracker (like a smartwatch) to monitor your symptoms weekly can help catch side effects from immunotherapy earlier. Immunotherapy is a type of cancer treatment that helps your body's immune system fight melanoma. The research team wants to see if real-time symptom tracking helps doctors identify and manage side effects more quickly.
Immunotherapy can cause unexpected side effects that develop during treatment, and catching them early is important for your safety and comfort. This study is looking at whether regular check-ins through your phone and a wearable device can help doctors spot problems sooner than waiting for scheduled clinic visits.
You likely qualify if…
You likely don't qualify if…
If you join, you'll complete questionnaires at the start, middle, and end of the study (about 3 months total). You'll wear a Fitbit activity tracker and answer a quick 5-minute symptom survey once a week via a secure link on your phone. You may also visit the cancer center at the beginning and end to complete a brief physical performance test. Half of participants will receive this remote monitoring, while the other half will receive usual care only.
AI-generated summary from trial data · Jul 18, 2026 · Not medical advice
United States
University of Pittsburgh
Enrollment target
~40 participants
Started
June 2026
Primary completion
December 2026
Age range
18 Years and older
Last updated on clinicaltrials.gov in July 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Carissa A Low
University of Pittsburgh
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.